The ciliostatic cystic fibrosis (CF) factor has been investigated in order to develop an enzymatic assay for its detection. In saliva, this factor is associated with a-amylase. Removal or addition of the factor by dialysis does not affect the a-amylase catalytic activity of C F or control (normal) saliva. Crude preparations of the dialyzable factor from C F saliva are ciliostatic.
a-Amylase-catalyzed starch hydrolysis from both C F and control saliva was found to be insensitive to hydroxyalkylamine inhibitors so this method could not be used to detect differences in C F and control amylase. Since another carbohydrase, mammalian debranching enzyme, is much more sensitive to inhibition, the effect of the isolated crude factor on this enzyme was determined. The mean values for percentage of inhibition of debranching enzyme activity by fractions obtained from saliva of C F patients, obligate heterozygotes, and control subjects are: 32% (27 samples), 13% (21 samples), and 6% (11 samples), respectively. Fifteen of the C F values exceed the maximum 13% inhibition observed for controls. Indeed, five samples almost completely inhibited debranching enzyme. This inhibitory action provides the basis of an enzymatic assay for the detection of the ciliostatic C F factor.
Speculation
These studies indicate that material isolated from C F saliva which contains ciliostatic activity also inhibits mammalian debranching enzyme. This action of the factor provides an enzymatic assay for its detection to replace the current bioassays. Although the assay is a useful method of detection for research purposes, lack of chemical quantitation of the factor at present precludes its use as a means of conclusively differentiating CF, carrier. or normal individuals.
Cystic fibrosis (CF) is a genetic disorder characterized by excessive exocrine gland activity, gastrointestinal malfunction, and progressive pulmonary disability (3, 9, 18). The basic defect is not known. However, factors have been found in the biological fluids of cystic fibrosis patients and obligate heterozygotes which may be related to the pathogenesis of the disease (5-8, 10, 14, 16, 17, 19, 26) . Factors present in serum, saliva and urine of C F homozygotes and heterozygotes interfere with the normal beat of various ciliated preparations (5, 10, 19, 26) . This activity is also present in the media of cultured fibroblasts from these individuals (6, 7) .
The ciliostatic factor from the saliva of C F patients appears to be associated with a-amylase (2, 10, 11). Bishop and coworkers have isolated two families of salivary a-amylase isozymes from cystic fibrosis saliva (2, 21)-These isozymes have disc gel electrophoretic mobilities identical with those of normal a-amylase isozymes but, unlike the normal enzyme, exhibit ciliostatic activity. These results would indicate that a salivary ciliostatic factor is either an isozyme of normal a-amylase, or a molecule carried by normal a-amylase through purification (21) .
This report presents the results of a determination of the relationship between a-amylase and the ciliostatic factor, as well as the basis for an improved assay for the ciliostatic C F factor. Obligate heterozygote saliva samples were obtained from the parents of C F patients, and control saliva samples were obtained from research associates and their children, who had no family history of CF. Small samples of whole saliva were collected with or without paraffin chewing to promote secretion. For larger samples, whole saliva was collected with the aid of Lifesaver lemon sour candy stimulation. Two candies were usually sufficient for collection of 30 ml of whole saliva. After collection, the saliva was centrifuged at 2,000 x g for 15 min and then filtered through glass wool. The filtrate was stored at 4' for less than 24 hr before initial assay or further use.
ENZYME ASSAYS
The a-amylase activity of saliva was determined using a modification of Fisher and Stein's procedure (12) . The rate of a-amylase catalyzed starch hydrolysis was measured at 30°, pH 6.5, in 0.05 M maleate buffer containing 0.01 M NaCI, 0.05% gelatin and 0.5% Merck soluble starch. The reaction was started by addition of saliva diluted with 0.05 M maleate buffer, pH 6.5, containing 0.01 M NaCl and 0.05% gelatin. After 15 min, the reaction was stopped by transfer to a boiling water bath for 2 rnin. The rate was determined by measuring the increase in reducing sugar concentration using a modification of the Nelson-Somogyi procedure, with glucose as a standard (25) . The effect of inhibitors is expressed as the relative activity of a-amylase in the presence and absence of the inhibitor. No maltase activity (23) could be detected under the assay conditions for starch hydrolysis. Polyamines, such as 0.05 M sperrnidine, interfered with the NelsonSomogyi reagent used for determination of reducing sugar concentration. Therefore, when necessary, the starch concentration was increased to 2.5% and the a-amylase concentration was increased by 10-fold. The boiled reaction mixture was then diluted 10-fold before addition of the Nelson-Somogyi alkaline copper reagent. This modification allowed use of higher concentrations of inhibitors. Mammalian debranching en/ymc from rabbit muscle (amylo-1,6-glucosidase/4-cu-glucanotr;1nsfcras) was purified as described previously (27) . Its activity was measured using glycogen phosphorylase limit dextrin as a substrate in the static assay described by Nelson, Kolb, and Larner (23).
Whole saliva collected without paraffin stimulation was used for this experiment. Dialysis tubing was presoaked to remove glycerol. The dialysis tubing used (Arthur Thomas, Va inch) is permeable to compounds of mol wt < 12,000. One milliliter of cystic fibrosis saliva filtrate was transferred to a dialysis sack, and dialyzed at 4", using a rocking dialyzer, against 3 ml of either normal saliva, or 0.05 M maleate buffer, pH 6.5, containing 0.01 M NaCl and 0.05% gelatin. Dialysis was continued for 96 hr. The material remaining in the sack and the dialysate were assayed for ciliostatic and a-amylase activity. Samples of saliva and buffer stored at 4' for the same period, but not dialyzed were also assayed to control for any changes not related to transfer of compounds of mol wt < 12,000.
PARTIAL PURIFICATION OF CILIOSTATIC FACTOR
Crude factor was obtained by extending Doggett and Harrison's method for the heparin treatment of saliva (10, 11) . Whole saliva collected with lemon sour candy stimulation was used. A solution of 10 mg/ml heparin (SchwarzlMann sodium salt 100,000 U/g) was added to the filtrate from 30 ml whole saliva to a final concentration of 0.5 mg/ml. Heparin-induced precipitate formation was complete in 48 hr at 4O. The mixture was centrifuged for 15 min at 10,000 x g and the resulting pellet was washed twice with 1 ml of aqueous heparin solution (0.5 mg/mi). The pellet was taken up in 1 ml of more concentrated heparin solution (10 mg/ml) and d~alyzed against 7-15 ml H,O overnight. The dialysate was lyophilized and stored at -20'. Up to 10 mg lyophilized dialysate was obtained. Before assay, the lyophilized dialysate was dissolved in 1 or 2 ml of water.
The effect of the heparin lyophilized dialysate on debranching enzyme was determined by addition of 10 to 100 p1 of the dialysate solution to a total of 200 pl in the standard limit dextrin static assay (27) . Controls run simultaneously contained 10-100 pl H,O in place of the dialysate solution. Ciliostatic activity of samples was measured at the Cystic Fibrosis Research Center at the Texas Institute of Rehabilitation and Research under the supervision of R. G. Doggett (10, 11) . Protein concentration was determined using the Folin-Lowry method (15, 20) . Absorbance was measured with a Gilford 240 or Cary 14 spectrophotometer. Amino acid analysis was performed by Dr. S. H. Bishop, on a Beckman model 1208 amino acid analyzer using ninhydrin for detection. pH values were measured at 25O. Deionized water was used in preparation of all solutions. 5-Amino-D-glucopyranose bisulfite (Nojirimycin bisulfate) was a gift from Dr. S. Inouye. Other chemicals used were of commercially available reagent grade.
RESULTS
Dialysis of whole C F and control saliva was done to determine the effect of partial removal or addition of constituents of mol wt < 12,000 on the ciliostatic and the amylase activities (Fig. I) .
These results indicate that at least some factor with ciliostatic activity can be transferred from C F saliva to control saliva or buffer by dialysis. The removal or addition of this factor does not affect the a-amylase activity of either C F or control saliva.
Preparations of the dialyzable ciliostatic factor were obtained free from a-amylase activity. Both the factor and a-amylase are precipitated from whole saliva by addition of heparin (10, 11) . Subsequent dialysis of the washed, resuspended precipitate separated the two activities. The dialyzable material is labile. In aqueous solution, at room temperature (25O), it loses its inhibitory activity on debranching enzyme in 6 days; at 4' it loses activity in 12 days. If stored at -20° and thawed only once before assay it loses 30% of its activity in 14 days. Additional lability studies are in progress to determine the best conditions for preserving its activity.
The dialyzed factor prepared by this heparin precipitate method from C F saliva is ciliostatic. It has a broad absorption maximum NORMAL SALIVA Fig. I . Effect of dialysis on ciliostatic and a-amylase activity of saliva. Solid bars indicate ciliostatic time. Slashed bars indicate relative amylase activity. a: effect on C F saliva; U , undialyzed activity; N, activity after dialysis against normal saliva; B, activity after dialysis against buffer, pH 6.5, 0.05 M Na-maleate, 0.05% gelatin, and 0.01 M NaCI. b: effect on normal saliva; U , undialyzed activity; CF, activity after dialysis against cystic fibrosis saliva. c: effect on buffer; U , undialyzed activity; CF, activity after dialysis against cystic fibrosis saliva. Cilia were observed for a period of 60 min. Samples in which cilia continue to beat for more than 60 min are considered to lack ciliostatic activity, (8).
at 274 nm. Protein as measured by the Folin-Lowry assay (15, 20) accounts for less than one-third of its absorption and less than one-fifth of its weight. Chemical analysis of this ciliostatic fraction indicates that it contains amide or secondary amino groups, hydroxyl groups, and possibly carbonyl groups. Amino acid analysis indicates that it is only slightly ninhydrin positive. No amino acid residues could be identified before or after acid hydrolysis. The material appears to contain an amide group since after acid hydrolysis the amino acid analyzer detected an ammonia peak. This preliminary analysis of the isolated factor suggests that it may be a polyamine metabolite, such as a hydroxyalkylamine (21) .
If C F amylase is a carrier for the ciliostatic factor. it might respond diffkrently to inhibitors of amylase catalytic activity. Therefore, the effect of polyhydroxyamines on a-amylase catalysis was tested (Table 1 ). The effect on rabbit muscle mammalian debranching enzyme is also shown, since hydroxyalkylamines have been found to be effective inhibitors of debranching enzyme (13, 21, 22) . The effect of these inhibitors on debranching enzyme increases with the degree of hydroxy group substitution (13, 22) . The most potent known reversible inhibitor of debranching enzyme, 5-amino-D-glucopyranose (Nojirimycin), has very little if any effect on a-amylase. It is evident that both cystic fibrosis and control a-amylase are insensitive to these compounds when starch is the substrate, and inhibition effects cannot differentiate between C F and normal a-amylase.
Since mammalian debranching enzyme (Table I) is over 100 times more sensitive to hydroxyalkylamine inhibitors than is a-amylase (13, 22, 24) , the effect of the dialyzed factor on the catalytic activity of debranching enzyme was tested (Fig. 2) . The mean values for the percentage of inhibition caused by the factor isolated from saliva of C F homozygotes, heterozygotes, and controls are 32% (27 samples), 13% (21 samples), and 6% (1 1 samples), respectively. The data does not follow a normal distribution. Twelve of the C F values fall in the range observed for normal values, 0-13%. whereas the other 15 values exceed 13% inhibition. The dialysis studies indicate that the ciliostatic factor is a -compound ,with mol wt < 12,000. This value is consistent with that reported recently for the factor isolated from serum as well as that isolated from culture media derived from various cystic fibrosis w cell lines (4). Like t k amine inhibitors, the factor does not affect o a-amylase starch hydrolysis. Apparently a-amylase acts as a carrier for the factor (1, 21). Compounds of this type, i.e., hydroxyalkylamines, bind to carbohydrases because of their structural resemblancce to glycosyl substrates (13, 21, 22) .
To facilitate further work on identification of the salivary Attempts to detect differences between C F and control a-amylase 
